2型糖尿病的神经认知损害:共享遗传病因学的证据
研究纳入1892名墨西哥裔美国人(含402例2型糖尿病患者),分析2型糖尿病与认知功能的遗传重叠。结果显示2型糖尿病与注意力、言语记忆及面孔记忆存在负向表型相关和负向遗传相关,提示认知损害可能是2型糖尿病的內表型。
要点
- 2型糖尿病与注意力、言语记忆及面孔记忆呈负向表型相关。
- 2型糖尿病与注意力、工作记忆及面孔记忆呈负向遗传相关。
- 认知损害可能是2型糖尿病的有用內表型。
核心结论
- 认知损害可能是2型糖尿病的有用內表型,有助于阐明该慢性病的病理生理基础。
研究设计与样本
- 利用来自扩展家系的1892名墨西哥裔美国人数据,其中402例患有2型糖尿病,采用综合神经心理学测试组合评估2型糖尿病与认知功能之间可能的基因多效性。
主要发现
- 2型糖尿病与注意力(连续操作测验CPT d':ρp=-0.143,p=0.001)、言语记忆(加利福尼亚言语学习测验CVLT回忆:ρp=-0.111,p=0.004)及面孔记忆(宾夕法尼亚面孔记忆测验PFMT:ρp=-0.127,p=0.002;PFMT延迟:ρp=-0.148,p=2×10⁻⁴)呈负向表型相关。
- 2型糖尿病与注意力(CPT d':ρg=-0.401,p=0.001)、工作记忆(数字倒背测验:ρg=-0.380,p=0.005)及面孔记忆(PFMT:ρg=-0.476,p=2×10⁻⁴;PFMT延迟:ρg=-0.376,p=0.005)呈负向遗传相关。
- 在注意力(CPT d':β=-0.219,p=0.005)、工作记忆(数字倒背:β=-0.326,p=0.035)及面孔记忆(PFMT:β=-0.171,p=0.023;PFMT延迟:β=-0.215,p=0.005)上,2型糖尿病个体表现最低,无血缘关系的未患病个体表现最高,与2型糖尿病个体有亲缘关系的个体表现居中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition. METHODS: Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we examined possible pleiotropy between type 2 diabetes and cognitive functioning, as measured by a comprehensive neuropsychological test battery. RESULTS: Negative phenotypic correlations (ρp) were observed between type 2 diabetes and measures of attention (Continuous Performance Test [CPT d']: ρp = -0.143, p = 0.001), verbal memory (California Verbal Learning Test [CVLT] recall: ρp = -0.111, p = 0.004) and face memory (Penn Face Memory Test [PFMT]: ρp = -0.127, p = 0.002; PFMT Delayed: ρp = -0.148, p = 2 × 10-4), replicating findings of cognitive impairment in type 2 diabetes. Negative genetic correlations (ρg) were also observed between type 2 diabetes and measures of attention (CPT d': ρg = -0.401, p = 0.001), working memory (digit span backward test: ρg = -0.380, p = 0.005), and face memory (PFMT: ρg = -0.476, p = 2 × 10-4; PFMT Delayed: ρg = -0.376, p = 0.005), suggesting that the same genetic factors underlying risk for type 2 diabetes also influence poor cognitive performance in these domains. Performance in these domains was also associated with type 2 diabetes risk using an endophenotype ranking value approach. Specifically, on measures of attention (CPT d': β = -0.219, p = 0.005), working memory (digit span backward: β = -0.326, p = 0.035), and face memory (PFMT: β = -0.171, p = 0.023; PFMT Delayed: β = -0.215, p = 0.005), individuals with type 2 diabetes showed the lowest performance, while unaffected/unrelated individuals showed the highest performance, and those related to an individual with type 2 diabetes performed at an intermediate level. CONCLUSIONS/INTERPRETATION: These findings suggest that cognitive impairment may be a useful endophenotype of type 2 diabetes and, therefore, help to elucidate the pathophysiological underpinnings of this chronic disease. DATA AVAILABILITY: The data analysed in this study is available in dbGaP: www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001215.v2.p2.
引用
- Mollon J, Curran JE, Mathias SR, et al. Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology. Diabetologia. 2020. PMID: 32016567. doi:10.1007/s00125-020-05101-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。